BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34128573)

  • 21. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER; Postma DS; Lawrance RM; Meyers DA; Ambrose HJ; Goldman M
    Lancet; 2007 Dec; 370(9605):2118-25. PubMed ID: 18156033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.
    Slob EMA; Vijverberg SJH; Palmer CNA; Zazuli Z; Farzan N; Oliveri NMB; Pijnenburg MW; Koppelman GH; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2018 Nov; 29(7):705-714. PubMed ID: 29992699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphic variants of the beta2-adrenergic receptor (ADRB2) gene and ADRB2-related propanolol-induced dyslipidemia in the Colombian population.
    Isaza C; Henao J; Ramirez E; Cuesta F; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):237-44. PubMed ID: 16082424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.
    Hizawa N; Makita H; Nasuhara Y; Betsuyaku T; Itoh Y; Nagai K; Hasegawa M; Nishimura M
    Chest; 2007 Nov; 132(5):1485-92. PubMed ID: 17890463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.
    Ni Chroinin M; Greenstone I; Lasserson TJ; Ducharme FM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005307. PubMed ID: 19821344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade.
    Hesse C; Schroeder DR; Nicholson WT; Hart EC; Curry TB; Penheiter AR; Turner ST; Joyner MJ; Eisenach JH
    J Physiol; 2010 Jul; 588(Pt 14):2669-78. PubMed ID: 20519311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of the association between ADRB2 gene polymorphisms and asthma in Kazakh population.
    Akparova A; Aripova A; Abishev M; Kazhiyakhmetova B; Pirmanova A; Bersimbaev R
    Clin Respir J; 2020 Jun; 14(6):514-520. PubMed ID: 32034992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults.
    Eisenach JH; Schroeder DR; Pavey ES; Penheiter AR; Knutson JN; Turner ST; Joyner MJ
    J Physiol; 2014 Dec; 592(23):5221-33. PubMed ID: 25260632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study.
    Hall IP; Blakey JD; Al Balushi KA; Wheatley A; Sayers I; Pembrey ME; Ring SM; McArdle WL; Strachan DP
    Lancet; 2006 Aug; 368(9537):771-9. PubMed ID: 16935688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of beta2-adrenergic receptor polymorphisms with severe asthma.
    Holloway JW; Dunbar PR; Riley GA; Sawyer GM; Fitzharris PF; Pearce N; Le Gros GS; Beasley R
    Clin Exp Allergy; 2000 Aug; 30(8):1097-103. PubMed ID: 10931116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADRB2 haplotype is associated with glucose tolerance and insulin sensitivity in obese postmenopausal women.
    Prior SJ; Goldberg AP; Ryan AS
    Obesity (Silver Spring); 2011 Feb; 19(2):396-401. PubMed ID: 20829805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.
    Altawalbeh SM; Thorpe CT; Zgibor JC; Kane-Gill S; Kang Y; Thorpe JM
    J Manag Care Spec Pharm; 2018 May; 24(5):478-486. PubMed ID: 29694289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis.
    Oba Y; Anwer S; Patel T; Maduke T; Dias S
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD013797. PubMed ID: 37602534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β(2) -adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from Colombia and their relationship to treatment response.
    Isaza C; Sepúlveda-Arias JC; Agudelo BI; Arciniegas W; Henao J; Porras GL; Beltrán L
    Pediatr Pulmonol; 2012 Sep; 47(9):848-55. PubMed ID: 22328447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association studies of exacerbations in children using long-acting beta2-agonists.
    Slob EMA; Richards LB; Vijverberg SJH; Longo C; Koppelman GH; Pijnenburg MWH; Bel EHD; Neerincx AH; Herrera Luis E; Perez-Garcia J; Tim Chew F; Yie Sio Y; Andiappan AK; Turner SW; Mukhopadhyay S; Palmer CNA; Hawcutt D; Jorgensen AL; Burchard EG; Hernandez-Pacheco N; Pino-Yanes M; Maitland-van der Zee AH
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1197-1207. PubMed ID: 33706416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.
    Kim SH; Ye YM; Hur GY; Lee HY; Jee YK; Lee SH; Holloway JW; Park HS
    Yonsei Med J; 2009 Apr; 50(2):182-8. PubMed ID: 19430548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.